×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📊
Dashboards
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Dashboards
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
←
Home
/
Wiki
/
Therapeutic: RNA-Targeting Therapies for Neurodegenerative Diseases
therapeutic
938 words
KG: RNA-Targeting Therapies for Neurodegenerative Diseases
Contents
RNA-Targeting Therapies for Neurodegenerative Diseases
💊
Therapeutic Info
Name
RNA-Targeting Therapies for Neurodegenerative Diseases
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (147)
Cross-Seeding Prevention Strategy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
Lysosomal Positioning Dynamics Modulation
Score: 0.69
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Flotillin-1 Stabilization Compounds
Score: 0.68
R-Loop Resolution Enhancement Therapy
Score: 0.68
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.67
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.67
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.67
Complement C1q Subtype Switching
Score: 0.66
RNA Granule Nucleation Site Modulation
Score: 0.66
← Prev
pg 5/8
Next →
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
What determines the specificity of DDR protein recruitment t
neurodegeneration · completed
How do dilncRNAs specifically drive molecular crowding and p
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Show 25 more
Related Experiments (30)
Sevoflurane-induced neurotoxicity (SIN) rat model
validation · proposed · Score: 0.95
FLS Stimulation and Transcriptomic Analysis
exploratory · proposed · Score: 0.95
Single-cell RNA-seq analysis of mouse testes with gonadal de
exploratory · proposed · Score: 0.95
Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m
validation · proposed · Score: 0.95
scRNA-seq analysis of human atherosclerotic plaques
exploratory · proposed · Score: 0.90
Gestational haloperidol exposure effects on hippocampal gene
validation · proposed · Score: 0.90
Single-cell RNA sequencing of mouse brains
exploratory · proposed · Score: 0.90
G3BP1-mediated stress granule assembly via liquid-liquid pha
exploratory · proposed · Score: 0.90
Factor depletion effects on DDR focus formation in vivo
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing of EMT states in SCC
exploratory · proposed · Score: 0.90
NPM1 knockout tumor progression study in syngeneic mice
validation · proposed · Score: 0.90
Multi-omics analysis of NP137 mechanism in patient biopsies
exploratory · proposed · Score: 0.90
DDR factor depletion and focus formation analysis
exploratory · proposed · Score: 0.90
LINC00599 expression analysis in hypoxic PH models
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing analysis of human atherosclerotic
exploratory · proposed · Score: 0.90
Sevoflurane-induced neurotoxicity (SIN) model in rats
validation · proposed · Score: 0.90
LINC00599 role in human PASMC proliferation
exploratory · proposed · Score: 0.90
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.90
Machine learning-based identification of C1Q hub genes
exploratory · proposed · Score: 0.90
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
LINC00599-MYH9 liquid-liquid phase separation analysis
exploratory · proposed · Score: 0.85
Single-cell RNA sequencing of microglial states in AD hippoc
exploratory · proposed · Score: 0.85
Microarray and single-cell RNA analysis of lipid metabolism
exploratory · proposed · Score: 0.85
Single-nucleus RNA-seq integration analysis
exploratory · proposed · Score: 0.85
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.85
Small RNA profiling of neonatal astrocyte EVs and microglia
exploratory · proposed · Score: 0.85
Netrin-1 and UNC5B knockdown effects on EMT in vitro
exploratory · proposed · Score: 0.85
DSB-induced promoter assembly and RNA polymerase II recruitm
exploratory · proposed · Score: 0.85
LC-MS/Western blot analysis of TBK1 in atherosclerotic arter
exploratory · proposed · Score: 0.80
BDEV injection and recipient microglial transcriptome analys
validation · proposed · Score: 0.80
Show 25 more
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)